ATE367806T1 - Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie - Google Patents

Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie

Info

Publication number
ATE367806T1
ATE367806T1 AT01961017T AT01961017T ATE367806T1 AT E367806 T1 ATE367806 T1 AT E367806T1 AT 01961017 T AT01961017 T AT 01961017T AT 01961017 T AT01961017 T AT 01961017T AT E367806 T1 ATE367806 T1 AT E367806T1
Authority
AT
Austria
Prior art keywords
chemotherapy
induced
patient
animal
aopezia
Prior art date
Application number
AT01961017T
Other languages
English (en)
Inventor
Richard Voellmy
Original Assignee
Richard Voellmy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richard Voellmy filed Critical Richard Voellmy
Application granted granted Critical
Publication of ATE367806T1 publication Critical patent/ATE367806T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
AT01961017T 2001-09-03 2001-09-03 Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie ATE367806T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2001/001607 WO2003020227A1 (en) 2001-09-03 2001-09-03 Compositions and methods relating to prevention of chemotherapy-induced alopecia

Publications (1)

Publication Number Publication Date
ATE367806T1 true ATE367806T1 (de) 2007-08-15

Family

ID=11004163

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01961017T ATE367806T1 (de) 2001-09-03 2001-09-03 Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie

Country Status (7)

Country Link
EP (1) EP1427383B1 (de)
JP (1) JP2005504063A (de)
AT (1) ATE367806T1 (de)
AU (1) AU2001282400B2 (de)
DE (1) DE60129606T2 (de)
ES (1) ES2291339T3 (de)
WO (1) WO2003020227A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099017A1 (en) * 2007-02-15 2008-08-21 Dignitana Ab Head cooler
WO2012028730A1 (en) 2010-09-02 2012-03-08 Thermather Sarl Device for thermal treatment of the scalp
JP5578997B2 (ja) * 2010-09-16 2014-08-27 国立大学法人 大分大学 がん化学療法誘発脱毛に対する抗脱毛用組成物
JP6458731B2 (ja) * 2013-09-04 2019-01-30 大正製薬株式会社 男性型脱毛症評価モデル
GB201317609D0 (en) 2013-10-04 2013-11-20 Cancer Rec Tech Ltd Inhibitor compounds
GB201505658D0 (en) 2015-04-01 2015-05-13 Cancer Rec Tech Ltd Inhibitor compounds
GB201617103D0 (en) 2016-10-07 2016-11-23 Cancer Research Technology Limited Compound
JP2019040648A (ja) * 2017-08-23 2019-03-14 株式会社東芝 磁気ディスク装置及びライト方法
US12440469B2 (en) 2019-09-02 2025-10-14 Syddansk Universitet P-gp inducers as protectors against chemotherapy-induced side effects, such as peripheral neuropathy (CIPN) and hair loss

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3724259A1 (de) * 1987-07-22 1989-02-02 Friedrich Bruenen Mittel zur bekaempfung von haarausfall, insbesondere von androgenetischem haarausfall
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
EP0656201A1 (de) * 1993-11-09 1995-06-07 Transcend Therapeutics, Inc. Verwendung von glutathionsynthesefordernden Substanzen als Haarwuchsmittel
WO1995023580A1 (en) * 1994-03-03 1995-09-08 Procyte Corporation Preventive and remedy for secondary depilation
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
US5830177A (en) * 1996-11-22 1998-11-03 Anticancer, Inc. Skin vibration method for topical targeted delivery of beneficial agents into hair follicles
DE69840980D1 (de) * 1997-01-21 2009-08-27 Voellmy Richard Verwendung des mutierten hitzeschock-transkriptionfaktors
WO1998046208A1 (en) * 1997-04-17 1998-10-22 The Regents Of The University Of Michigan Hair follicle dna delivery system
US7405080B2 (en) * 2000-03-23 2008-07-29 Voellmy Richard W Compositions and methods relating to prevention of chemotherapy-induced alopecia

Also Published As

Publication number Publication date
WO2003020227A1 (en) 2003-03-13
AU2001282400B2 (en) 2009-04-23
DE60129606D1 (de) 2007-09-06
ES2291339T3 (es) 2008-03-01
EP1427383A1 (de) 2004-06-16
JP2005504063A (ja) 2005-02-10
EP1427383B1 (de) 2007-07-25
DE60129606T2 (de) 2008-05-21

Similar Documents

Publication Publication Date Title
TW200612987A (en) Combination treatment for non-hematologic malignancies
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
NO20014842L (no) Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2003094836A3 (en) Methods and products for enhancing immune responses using imidazoquinoline compounds
ATE405564T1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
DE60118547D1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
BRPI0414568A (pt) combinações de drogas para o tratamento de neoplasmas
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
DE50006156D1 (de) Vorrichtung und verwendung zur steigerung der transdermalen permeation von arzneistoffen
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
ATE367806T1 (de) Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE359072T1 (de) Methode und zusammensetzung zur behandlung von resistenz gegen antihypertensiva und verwandten zuständen
DE69822810D1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
ATE454896T1 (de) Heilkräuterzusammensetzung zur behandlung von aids
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
ATE409495T1 (de) Polynukleotide-bindende komplexe die sterolen und saponine enthalten
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427383

Country of ref document: EP